Let’s Partner to Win
Guided by Play-to-Win strategy, Sanofi Partnering works with innovators to bring the most promising medicines to patients. We are inspired by the possibilities of transformative science and the creativity of innovators to change the lives of patients worldwide.
External collaborations play a major role in Sanofi's pipeline development. Over the years, we have transformed patients’ lives by delivering breakthrough medicines, working in close partnership with innovators. We win with our partners.
Together we can be faster, more ambitious in clinical development, bring products to more patients in more geographies, optimize CMC and manufacturing, and create a powerful ecosystem supporting our medicines.
"We’re constantly on the lookout for game-changing medicine. Our focus is transformation – building tomorrow’s healthcare, with partners striving to bring innovation to patients worldwide."
Alban de La Sablière, Head of Sanofi Partnering
Sanofi Partnering invests in early-stage companies through Sanofi Ventures, develops win-win partnerships through BD&L while building a strong and seamless collaboration to ensure the successful development and commercialization of medicines through Alliance Management.
Because we are keenly aware that time is a scarce resource, we value a straightforward and direct communication and a collaborative approach to problem solving. All of that with direct access and involvement of Sanofi senior leadership. Our goal is to make it simple while delivering the breadth of our expertise. We believe this is key to bringing transformative medicines to patients with our partners.
Partnering for the Future
John Reed, Global Head of R&D, and Alban de La Sablière, Head of Sanofi Partnering, share how Sanofi's latest partnerships can accelerate the pace of R&D innovation and fuel its long-term success in oncology and immunology.